Skip to content

Efficacy Study of a Sensory Feedback Knee Orthosis in Patients Suffering From Unoperated Severe Knee Sprain

Status
Terminated
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01508728
Acronym
ORTHOSENS
Enrollment
104
Registered
2012-01-12
Start date
2012-03-31
Completion date
2013-09-30
Last updated
2014-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sprain

Keywords

unoperated severe sprain of the knee with partial or total rupture of the anterior, cruciate ligament and medial or lateral collateral ligament

Brief summary

Ortheses are commonly used for the repair of damage to the musculoskeletal system. However, immobility, by itself, causes serious side effects that require long and costly rehabilitation. The Sensory Feedback Ortheses allow to artificially maintain the proprioceptive and tactile flow in order to maintain the activity of their host brain areas and thus reduce significantly the usual therapy duration. The clinical study Orthosens will evaluate the efficacy and safety of the Sensory Feedback Ortheses.

Interventions

DEVICEORTHOSENS orthosis

with active vibration

Sponsors

Thuasne
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients agreeing to participate in the study and who signed informed consent. * Indication of bracing immobilization for 6 weeks following a unoperated severe sprain of the knee with partial or total rupture of the anterior cruciate ligament and a peripheral injury, medial or lateral collateral ligament, with or without meniscal lesion. * MRI scan confirming the nature of the lesion to be provided during the inclusion visit. * Patients whose knee is immobilized for 7 to 15 days in Zimmer-like splint. * Patients aged from 18 to 65. * Patients agreeing to choose their physiotherapist from a list provided by the investigators. * Patient (s) with insurance coverage.

Exclusion criteria

* Patients with a bucket handle meniscus tear. * Patients with a pentad injury. * Patients with osteochondral fragments. * Patients with a knee fracture apart from Segond fracture and bone bruise. * Patients who underwent ligament surgery for the concerned knee. * Patients with a bone lesion which may interfere with the knee joint(distal femur, proximal tibia, patella). * Patients with any history of rupture of the central pivot (anterior cruciate ligament and posterior cruciate ligament), of lateral ligament planes rupture (medial collateral ligament and lateral collateral) or lateral planes ligament injury without rupture, dating from less than 1 year. * Patients whose sprain results from an accident at work. * Patients with an inability / unwillingness to follow protocol requirements. * Patients for whom there would be no suitable brace size in the Thuasne range. * Patients participating in another clinical study or who have tested an experimental drug within 30 days prior to study entry. - Patients with another disease which, according to the investigator, may interfere with the results or the conduct of the trial and thus justify their non-inclusion in the study.

Design outcomes

Primary

MeasureTime frame
Period of time required to recover a normal knee range of motion

Secondary

MeasureTime frame
Safety according to adverse event recordsAt any time during subject participation (12 weeks)
Period of time required to recover a normal knee range of motion with a passive mobilizationThe day of inclusion, then 3 times per week during 12 weeks (except at weeks 8 and 12: 4 measurements)
Pain according to Visual Analogic ScaleThe day of inclusion, then 3 times per week during 12 weeks (except at weeks 8 and 12: 4 measurements)
Psychological state according to the Incredibly Short Profile of Mood States3 times per week from week 1 to week 12
Knee functional state according to IKDC, KOOS and KOOS-PS scoresThe Day of inclusion, then 3 times per week during 12 weeks (except at weeks 8 and 12: 4 measurements)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026